Adderall is in short supply, according to the FDA Drug Shortages website.
Of the five companies that currently sell adderall, Mylan is
completely out of stock, Nesher can’t get the active ingredient and
Aurobindo has the drug under allocation. Only Teva and Sandoz show they
have Adderall available.
“The situation shows how sensitive the U.S. generic system has
become. There is limited spare capacity and even commodity products can
come out of stock,” analyst Ronny Gal, PhD, wrote to investors,
according to STAT.
https://www.beckershospitalreview.com/pharmacy/adderall-in-short-supply-fda-website-shows.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.